Bladder Cancer Clinical Trial

The Personal Patient Profile Decision Support for Patients With Bladder Cancer

Summary

There is a pressing need to develop a personalized, value-based decisional tool for bladder cancer patients undergoing radical cystectomy (bladder removal) and urinary diversion to help them with communication with the physicians, shared decision making, and preparation for disease-management and follow-up care. The proposed intervention, the Personal Patient Profile - Bladder Cancer (P3-BC), will be the first intervention to address these issues. Results of this pilot randomized feasibility study will provide evidence of the feasibility and acceptability of the P3-BC and will guide further refinement of the tool for a larger experimental trial, with potential dissemination of the program via the Internet and hand-held computing devices.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients: cystectomy for MIBC and NMIBC;
at least 18 years;
able to communicate in English; and
competent to give consent.

Exclusion Criteria:

- Existence of other cancers or ongoing cancer treatment.

Study is for people with:

Bladder Cancer

Estimated Enrollment:

45

Study ID:

NCT05033067

Recruitment Status:

Recruiting

Sponsor:

Icahn School of Medicine at Mount Sinai

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

How clear is this clinincal trial information?

Study is for people with:

Bladder Cancer

Estimated Enrollment:

45

Study ID:

NCT05033067

Recruitment Status:

Recruiting

Sponsor:


Icahn School of Medicine at Mount Sinai

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.